.jpeg)
As Chief Scientific Officer, Dr. Pamela Tenaerts oversees Medable’s clinical research department to help identify, develop and implement...
Leveraging decentralized clinical trials (DCTs) effectively could help diversify the patient population, create new trial opportunities for sites, and improve quality of operations, says Dr. Pamela Tenaerts, who has just joined Medable as its Chief Scientific Officer.
Thought leader Tenaerts’s opinions are fueled by more than 30 years of clinical research experience, most recently as executive director of the Clinical Trials Transformation Initiative (CTTI) at Duke University.
